Minerva Surgical (UTRS) Competitors

Nemaura Medical (NASDAQ:NMRD) and Minerva Surgical (NASDAQ:UTRS) are both small-cap medical companies, but which is the better stock? We will contrast the two companies based on the strength of their valuation, institutional ownership, risk, earnings, analyst recommendations, dividends, media sentiment and profitability.

Is NMRD or UTRS more profitable?

Company	Net Margins	Return on Equity	Return on Assets
Nemaura Medical	N/A	N/A	N/A
Minerva Surgical	N/A	N/A	N/A

Does the media prefer NMRD or UTRS?

In the previous week, Nemaura Medical's average media sentiment score of 0.00 equaled Minerva Surgical'saverage media sentiment score.

Company	Overall Sentiment
Nemaura Medical	Neutral
Minerva Surgical	Neutral

Do insiders & institutionals believe in NMRD or UTRS?

4.4% of Nemaura Medical shares are held by institutional investors. 40.4% of Nemaura Medical shares are held by company insiders. Comparatively, 8.5% of Minerva Surgical shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

Which has more volatility and risk, NMRD or UTRS?

Nemaura Medical has a beta of 0.5, suggesting that its share price is 50% less volatile than the S&P 500. Comparatively, Minerva Surgical has a beta of 3.55, suggesting that its share price is 255% more volatile than the S&P 500.

Which has higher earnings and valuation, NMRD or UTRS?

Nemaura Medical has higher earnings, but lower revenue than Minerva Surgical.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Nemaura Medical	$3.02K	2.67	-$14.14M	-$0.39	0.00
Minerva Surgical	$51.69M	0.00	-$34.11M	N/A	N/A

Summary

Nemaura Medical beats Minerva Surgical on 3 of the 5 factors compared between the two stocks.